Institute for Clinical and Economic Review (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Institute for Clinical and Economic Review" in English language version.

refsWebsite

Global rank English rank

4icer.org

low place

3nih.gov

4^th place

2fiercepharma.com

low place

8,921^st place

1statnews.com

8,771^st place

5,253^rd place

1web.archive.org

1^st place

1ajpb.com

low place

1modernhealthcare.com

low place

1wsj.com

79^th place

65^th place

1oup.com

485^th place

440^th place

1doi.org

2^nd place

1house.gov

529^th place

314^th place

1forbes.com

54^th place

48^th place

1thepharmaletter.com

low place

1icer-review.org

low place

ajpb.com

"Institute for Clinical and Economic Review Seeks to Enhance Healthcare Value". Ajpb.com. Archived from the original on 14 November 2023. Retrieved 25 June 2019.

doi.org

Kirkdale, R; Krell, J; O'Hanlon Brown, C; Tuthill, M; Waxman, J (2010). "The cost of a QALY". QJM: Monthly Journal of the Association of Physicians. 103 (9): 715–720. doi:10.1093/qjmed/hcq081. PMID 20519275. Retrieved 27 May 2021.

fiercepharma.com

"Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says". FiercePharma.com. Retrieved 25 June 2019.
"Are new bone drugs from Amgen and Radius cost-effective? Not even close, ICER says". FiercePharma.com. Retrieved 25 June 2019.

forbes.com

Cohen, Joshua. "Throwing The Baby Out With The Bath Water: Congress Considers Banning The QALY". Forbes. Retrieved 2023-11-22.

house.gov

mcmorris.house.gov

"McMorris Rodgers Leads Legislation to Ban QALYs, Protect Individuals with Disabilities from Discrimination". Cathy McMorris Rodgers. Retrieved 2023-11-22.

icer-review.org

"Materials". Icer-review.org. Retrieved 25 June 2019.

icer.org

"Value Assessment Framework". ICER. Retrieved 2021-03-31.
"Cost-Effectiveness, the QALY, and the evLYG". ICER. Retrieved 2021-03-31.
"ICER Finalizes 2023 Updates to Value Assessment Framework". ICER. Retrieved 2023-11-22.
"Methods Update: Value Assessment Framework". ICER. Retrieved 2023-11-22.

modernhealthcare.com

"Series of reports will analyze cost, benefit of pricey drugs". Modern Healthcare. 21 July 2015. Retrieved 25 June 2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

Pizzi, LT (2016). "The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare". Am Health Drug Benefits. 9 (1): 9–10. PMC 4822973. PMID 27066190.
Kirkdale, R; Krell, J; O'Hanlon Brown, C; Tuthill, M; Waxman, J (2010). "The cost of a QALY". QJM: Monthly Journal of the Association of Physicians. 103 (9): 715–720. doi:10.1093/qjmed/hcq081. PMID 20519275. Retrieved 27 May 2021.

ncbi.nlm.nih.gov

Pizzi, LT (2016). "The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare". Am Health Drug Benefits. 9 (1): 9–10. PMC 4822973. PMID 27066190.

oup.com

academic.oup.com

Kirkdale, R; Krell, J; O'Hanlon Brown, C; Tuthill, M; Waxman, J (2010). "The cost of a QALY". QJM: Monthly Journal of the Association of Physicians. 103 (9): 715–720. doi:10.1093/qjmed/hcq081. PMID 20519275. Retrieved 27 May 2021.

statnews.com

"This nonprofit is helping frame the drug prices discussion". Statnews.com. 12 April 2016. Retrieved 25 June 2019.

thepharmaletter.com

"ICER to use new metric to assess drug cost-effectiveness". www.thepharmaletter.com. Retrieved 2023-11-22.

web.archive.org

"Institute for Clinical and Economic Review Seeks to Enhance Healthcare Value". Ajpb.com. Archived from the original on 14 November 2023. Retrieved 25 June 2019.

wsj.com

Roland, Denise (4 November 2019). "Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs". Wall Street Journal. Retrieved 27 May 2021.